Company: LRHC
Filing Date: 2025-07-17
Form Type: 424B3
Source: 0001213900-25-065175
Chunk: 7

Company: La Rosa Holdings Corp.
Filing Date: 2025-07-17
Form: 424B3
Chunk 7
---
 $1.00 per share required for continued listing on
The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule
5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until April 8, 2025 (the “Compliance Period”),
to regain compliance with the Bid Price Rule. In order to regain compliance with the Bid Price Rule, our common stock was required to
maintain a minimum closing bid price of $1.00 for a minimum of ten consecutive business days during the Compliance Period prior to April
9, 2025.

As of April 8, 2025, the common stock has not
regained compliance with the Bid Price Rule. However, in a letter dated April 9, 2025 (the “Second Nasdaq Bid Price Letter”),
Nasdaq notified the Company that Nasdaq’s Staff has determined that the Company is eligible for an additional 180 calendar day
period, or until October 6, 2025, to regain compliance (the “Second Compliance Period”). As of the date of this report our
common stock has not regained compliance with the Bid Price Rule. If the Company chooses to implement a reverse stock split, it must
complete the split no later than ten business days prior to the end of the Second Compliance Period in order to timely regain compliance.
If we fail to regain compliance with the Bid Price Rule within the Second Compliance Period, or if we fail to continue to meet all applicable
continued listing requirements for Nasdaq in the future, Nasdaq could delist our securities.

The Second Nasdaq Bid Price Letter has no immediate
effect on the listing or trading of the common stock. Our common stock continues to be listed on the Nasdaq Capital Market under the
symbol “LRHC”. We are currently evaluating our options for regaining compliance.

Amendment to CEO Employment Agreement

On February 3, 2025, on the approval of the Compensation
Committee of the Board of Directors (the “Compensation Committee”) of the Company amended the employment agreement between
the Company and Joseph La Rosa, the Company’s Chief Executive Officer. The amendment provided Mr. La Rosa with a right to receive
certain annual equity awards and milestone equity awards not only in the form of stock options but also in the form of restricted stock
units and amended Section 4.3(b) to include